ストックスクリーナーアプリを入手
39.00
0.31%
0.1204
前日終値:
$38.88
開ける：
$39
24時間の取引高:
20,591
Relative Volume:
0.67
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+4.21%
1か月 パフォーマンス:
+8.39%
6か月 パフォーマンス:
+29.17%
1年 パフォーマンス:
+69.98%
1日の値動き範囲:
$38.39
$39.16
1週間の範囲:
$37.14
$39.16
52週間の値動き範囲:
$22.48
$39.16
Tema Oncology Etf Stock (CANC) Company Profile
Compare CANC vs VTI, SPY, IVV, VB, QQQ
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CANC
Tema Oncology Etf
|
39.00 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
345.24 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
699.94 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
703.19 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
278.28 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
637.40 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Oncology Etf (CANC) 最新ニュース
Discipline and Rules-Based Execution in CANC Response - Stock Traders Daily
GNOM, CANC, IBB: Healthcare ETFs Build Long-Term Wealth for Investors - TipRanks
CANC: I Give A Hold Rating To This ETF That Invests In Cancer-Fighting Stocks - Seeking Alpha
CANC Stock Price, Quote & Chart | TEMA ONCOLOGY ETF (NASDAQ:CANC) - ChartMill
CANC: First Look At This Addressing Cancer ETF Results In A Hold Rating (Retired Investor) (NASDAQ:CANC) - Seeking Alpha
Behavioral Patterns of CANC and Institutional Flows - Stock Traders Daily
(CANC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Biotech stocks and longevity investing: Trends to track - North Scott Press
CANC Stock Chart | TEMA ONCOLOGY ETF (NASDAQ:CANC) - ChartMill
Biotech Stocks & Longevity Investing: Trends to Track - The Motley Fool
Why Is Cogent Biosciences Stock Surging Monday?Cogent Biosciences (NASDAQ:COGT) - Benzinga
Land and Houses Asset Management launches LHLONGEVITY, investing in innovative cancer treatment stocks. - moneyandbanking.co.th
Cogent Biosciences Stock Climbs After FDA Accepts Key Drug Application - sahmcapital.com
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share - AOL.com
ETFs Investing in Adlai Nortye Ltd. Sponsored ADR Stocks - TradingView
How (CANC) Movements Inform Risk Allocation Models - Stock Traders Daily
2 Under-the-Radar Stocks to Buy and Hold - AOL.com
Healthcare stocks are red-hot. Here are 3 picks from a fund manager up 41% this year. - MSN
GNOM, CANC, IBB: Use Targeted Healthcare ETFs to Build Wealth - TipRanks
F/m High Yield 100 ETF (NASDAQ:ZTOP) Shares Down 0.2% – Time to Sell? - Defense World
Trading Systems Reacting to (CANC) Volatility - Stock Traders Daily
11 Best Cancer Stocks to Invest In Now - Insider Monkey
How Tema Oncology Etf (CANC) Affects Rotational Strategy Timing - Stock Traders Daily
Thrivent Financial for Lutherans Decreases Stake in Tema Oncology ETF $CANC - Defense World
(CANC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
2 Stocks That Could Soar This Year - AOL.com
This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy? - AOL.com
Responsive Playbooks and the CANC Inflection - Stock Traders Daily
Understanding the Setup: (CANC) and Scalable Risk - Stock Traders Daily
Tema Oncology ETF (NQ: CANC - FinancialContent
Here's Why Biotech ETFs Are Rallying Hard - Zacks Investment Research
Los Angeles Daily NewsTema Oncology ETF (Nasdaq:CANC) Stock Quote - FinancialContent
The Technical Signals Behind (CANC) That Institutions Follow - Stock Traders Daily
Biotech Market Forecast: Top Trends for Biotech in 2026 - Investing News Network
Avoiding Lag: Real-Time Signals in (CANC) Movement - Stock Traders Daily
ETFs Investing in Ascentage Pharma Group International Unsponsored ADR Stocks - TradingView — Track All Markets
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - PharmiWeb.com
The AI Pharma Rally Is Real — And Cancer May Soon Be Chronic, Not Deadly - Sahm
Be Thankful to These ETFs This Year - sharewise.com
Inside the Recent Strength in Biotech ETFs - TradingView
Biotech ETFs Bounce Back in 2025: Here's Why - sharewise.com
Aug PostEarnings: Is Tema ETF Trust Tema International stock among top earnings playsInsider Selling & Reliable Volume Spike Trade Alerts - nchmf.gov.vn
5 Small-cap Biotech ETFs to Watch in 2025 - Nasdaq
ETFs with Bristol-Myers Squibb Company ( BMY ) Exposure - ETF Database
Tema Launches Alternative Asset Managers ETF (AAUM) - Business Wire
Tema Launches First International Defense Innovation ETF (GDFN) - Business Wire
2 Growth Stocks to Buy and Hold Forever - AOL.com
Tema Launches International Durable Quality ETF (ITOL) - Business Wire
Tema Surpasses $1bn AUM Two Years After Launch, Strengthens Team With Key Growth Hires - Business Wire
Tema Announces Liquidation of Two ETFs - Business Wire
Bristol-Myers Squibb At ASCO 2025: A Resilient Play Amid Market Turbulence (NYSE:BMY) - Seeking Alpha
Tema Oncology Etf (CANC) 財務データ
Tema Oncology Etf (CANC) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.45%
1.88%
大文字化:
|
ボリューム (24 時間):